CEPH Message Board - Msg: 1787171

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CEPH

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: WeirdPro Randy who wrote (403)	7/17/1997 10:04:00 PM
From: harkenman	of 998

Rhone-Poulenc Rorer's Rilutek Cleared For 5 Added Countries Dow Jones Newswires COLLEGEVILLE, Pa. -- Rhone-Poulenc Rorer Inc. (RPR) received marketing clearance in five added countries for Rilutek Tablets used to treat amyotrophic lateral sclerosis, or Lou Gehrig's disease. In a press release Thursday, Rhone-Poulenc said the five countries are Colombia, Mexico, Peru, Uruguay and Israel. In total Rilutek has been cleared for marketing in 26 countries. Phone-Poulenc is a pharmaceutical company. interactive4.wsj.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next